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Tight junctions (TJs) connect epithelial cells and form a semipermeable barrier that only allows
selective passage of ions and solutes across epithelia. Here we show that mice lacking EpCAM, a
putative cell adhesion protein frequently overexpressed in human cancers, manifest intestinal barrier
defects and die shortly after birth as a result of intestinal erosion. EpCAM was found to be highly
expressed in the developing intestinal epithelium of wild-type mice and to localize to cell–cell
junctions including TJs. Claudin-7 colocalized with EpCAM at cell–cell junctions, and the two proteins
were found to associate with each other. Claudins 2, 3, 7, and 15 were down-regulated in the intestine
of EpCAM mutant mice, with claudin-7 being reduced to undetectable levels. TJs in the mutant
intestinal epithelium were morphologically abnormal with the network of TJ strands scattered and
dispersed. Finally, the barrier function of the intestinal epithelium was impaired in the mutant animals.
These results suggest that EpCAM contributes to formation of intestinal barrier by recruiting claudins to
cell–cell junctions.
& 2012 Published by Elsevier Inc.Introduction
During our search for pluripotency-associated genes in embry-
onal carcinoma cell lines (Saijoh et al., 1996), we identiﬁed EpCAM
as a gene that is speciﬁcally expressed in undifferentiated cells.
Previous studies have revealed that EpCAM contributes to various
biological processes including cell signaling, migration, and pro-
liferation (de Boer et al., 1999; Litvinov et al., 1997; Maghzal et al.,
2010). EpCAM was originally identiﬁed as a tumor-associated
antigen on the basis of its high level of expression in rapidly
growing tumors of epithelial origin (Trzpis et al., 2007). EpCAM-
positive cells have been suggested to serve as cancer stem cells
for various human cancers including colorectal and hepatocellular
carcinoma (Dalerba et al., 2007; Yamashita et al., 2009). A
proteolytic fragment of EpCAM containing the intracellular
domain was recently shown to form a complex with b-catenin
and Lef-1 that translocates to the nucleus and activates theElsevier Inc.
cs Group, Graduate School of
oka, Suita, Osaka 565-0871,
.jp (S. Tsukita),
.transcription of genes related to cell proliferation, such as those
for c-Myc and cyclins A and E, and thereby to promote oncogen-
esis (Maetzel et al., 2009). EpCAM is also implicated in main-
tenance of pluripotency in embryonic stem cells (Gonzalez et al.,
2009; Lu et al., 2010) as well as in somatic stem cells such as
hepatic stem cells (Okabe et al., 2009; Schmelzer et al., 2006;
Schmelzer et al., 2007; Tanaka et al., 2009).
EpCAM (CD326, also known as Tacstd1), a type I transmem-
brane glycoprotein that contains two EGF-like domains, a single
transmembrane domain, and a small intra cellular domain (Winter
et al., 2003), has been implicated in homotypic cell–cell adhesion
in epithelia (Litvinov et al., 1994), but its precise role in epithelial
cell adhesion remains unclear. A recent study of zebraﬁsh lacking
EpCAM suggested that this protein functions as a partner of
E-cadherin in epithelial morphogenesis during epiboly and skin
development (Slanchev et al., 2009). Adhesive structures between
adjacent cells, including tight junctions (TJs) and adherens junc-
tions (AJs), are not only required for tissue integrity but also act as
signaling structures. While adhesion at AJs is mediated by cadher-
ins, a conserved family of adhesion molecules, TJs contain many
adhesive molecules including claudins, occludin, ZO-1 and junc-
tional adhesion molecules (JAMs) (Tsukita et al., 2001).
Although EpCAM is implicated in various biological events, its
physiological function remains unclear. To investigate the func-
tion of EpCAM in vivo, we generated two EpCAM knockout mouse
Z. Lei et al. / Developmental Biology 371 (2012) 136–145 137models by gene targeting. We now show that EpCAM contributes
to formation of functional TJs in the intestinal epithelium by
recruiting claudin proteins to apical cell–cell junctions.Materials and methods
Mice
Two mutant alleles of the EpCAM gene were generated by gene
targeting in embryonic stem cells (Fig. S2): the EpCAMbgeo allele,
in which a bgeo cassette and a loxP site are inserted into intron
1 and another loxP site is inserted into intron 3; and the EpCAM–
allele, in which exons 2 and 3 are deleted. Both mutant alleles are
functionally null. Heterozygous mutant mice were maintained
on the 129/C57B6 mixed background. All experiments were
approved by the Institutional Animal Care and Use Committee
of the Osaka University.
Histological analysis and immunostaining
For histological analysis, tissue was ﬁxed overnight at 4 1C in
PBS containing 4% paraformaldehyde, dehydrated, embedded in
parafﬁn, sectioned, and stained with hematoxylin–eosin. Alcian
blue staining was performed according to standard protocols.
Frozen sections were stained for 30 min at room temperature
with 1% AB 8GX (Sigma) in 3% acetic acid, and then counter-
stained with nuclear fast red. For X-gal staining, frozen sections
were stained overnight at 37 1C with a pH 7.3 solution containing
2 mM MgCl2, 4 mM potassium ferricyanide, 4 mM potassium
ferrocyanide and 0.1% X-gal in PBS. For alkaline phosphatase
staining, the sections were stained for 30 min at room tempera-
ture with NBT/BCIP (Roche) in 100 mM NaCl, 100 mM Tris–HCl
(pH9.5), 50 mM MgCl2 and 0.1% Tween20. For immunostaining,
frozen sections (thickness of 7 mm) were exposed to 1% BSA in PBS
containing 0.1% Tween-20 to block nonspeciﬁc sites before
incubation ﬁrst overnight at 4 1C with primary antibodies and
then for 1 h at room temperature with secondary antibodies.
Primary antibodies included rat anti-Ki67 (1:1500 dilution,
M724901) from DakoCytomation; mouse anti-c-Myc (1:200,
sc-40) and goat anti-EpCAM (1:200, sc-23788) from Santa Cruz
Biotechnology; rabbit anti-claudin-7 (1:1000, #34-9100) from
Zymed; rabbit anti-claudin-15 (1:250, #38–9200), mouse
anti–claudin-2 (1:250, #32-5600), rabbit anti-claudin-3 (1:200,
#34-1700), and mouse anti-plakoglobin (1:300, #138500) from
Invitrogen; rat anti-occludin, rat anti-ZO-1, and rat anti-E-cad-
herin generated in-house; rabbit anti-cleaved caspase3 (1:100,
#9661) from Cell signaling and rabbit anti-EpCAM (1:1000,
ab32392) from Abcam. Immunoﬂuorescence analysis was per-
formed with Alex Fluor 488- or Alexa Fluor 568-labeled secondary
antibodies (Invitrogen), whereas immunohistochemical analysis
was performed with biotin-conjugated secondary antibodies
(Jackson laboratory), HRP-ABC complex (VECTASTAIN) and DAB
(DOJINDO). Use Zeiss or Olympus confocal microscope to observe
the immunoﬂuorescence sections, and immunohistochemical
photos were got by using Nikon microscope and Olympus camera.
In situ hybridization
The intestine was ﬁxed overnight at 4 1C with 4% paraformal-
dehyde in PBS, dehydrated, embedded in OCT compound, and
sectioned at a thickness of 7 mm. The sections were ﬁxed again
with 4% paraformaldehyde in PBS, treated with 0.2 M HCl,
digested with proteinase K, re-ﬁxed with 4% paraformaldehyde
in PBS, treated with 0.25% acetic anhydride, and subjected to
hybridization for 24–48 h at 55 1C with speciﬁc digoxigenin-labeled probes in 5 SSC (pH 5.0) containing 50% formamide,
1% SDS, yeast tRNA (50 mg/ml), and heparin (50 mg/ml). Sections
were then washed at 55 1C shortly ﬁrst with 5 SSC and then
with 2 SSC containing 50% formamide for 15 min before incuba-
tion for 30 min at 37 1C with RNase A (10 mg/ml; Sigma ) in TNE
buffer [10 mM Tris–HCl (pH 8.0), 500 mM NaCl, 1 mM EDTA].
After washing twice for 20 min with 2 SSC and then twice for
20 min with 0.2 SSC at 50 1C, the sections were incubated at
room temperature ﬁrst for 5 min in TBS containing 0.1% Tween 20
and then for 1 h in the same solution containing 1% blocking
powder (Roche). They were subsequently incubated overnight at
4 1C with the blocking solution containing alkaline phosphatase–
conjugated antibodies to digoxigenin (1:2000 dilution; Roche).
After several washes with TBS containing 0.1% Tween 20, immune
complexes were detected with NBT/BCIP solution (Roche). The
sections were ﬁnally dehydrated with a graded series of ethanol
solutions and permanently mounted on glass slides. Microscopic
analysis was performed as described for immunostaining. Whole-
mount in situ hybridization was performed according to standard
protocols (Wilkinson, 1992).
Immunoprecipitation and immunoblot analysis
The entire intestine of E18.5 embryos was homogenized by
hand for 1 h on ice in lysis buffer [25 mM Hepes–NaOH (pH 7.2),
150 mM NaCl, 5 mM MgCl2] containing 1% CHAPS (Kuhn et al.,
2007) as well as a protease inhibitor cocktail (Roche) and 2 mM
PMSF. The homogenate was centrifuged at 17,600g for 10 min at
4 1C, and the resulting supernatant (1 ml) was incubated for 2 h at
4 1C with 1/10 volume of protein G-Sepharose (GE Healthcare)
and protease inhibitor cocktail. After removal of the resin by
centrifugation, the tissue lysate was incubated overnight at 4 1C
with 3 mg of speciﬁc antibodies or control IgG, with protein G-
Sepharose being added for the ﬁnal 4 h. The resin was then
isolated by centrifugation, washed six times with lysis buffer,
and subjected to SDS-PAGE on a 12% or 15% gel. The separated
proteins were transferred electrophoretically to a polyvinylidene
diﬂuoride membrane overnight at 30–40 V and 4 1C, after which
the membrane was exposed to a solution containing 3% nonfat
milk powder and 0.1% Tween 20 before immunoblot analysis
with primary antibodies and ECL Plus reagents (Amersham).
Primary antibodies included goat anti-EpCAM (1:25 dilution; sc-
23788,Santa Cruz Biotechnology), rabbit anti-claudin-7 (1:5000;
#34-9100, Zymed), rabbit anti-claudin-3 (1:500; #34-1700, Invi-
trogen), mouse anti-claudin-2 (1:500; #32-5600, Invitrogen), and
rabbit anti-claudin-15 (1:250; #38-9200, Invitrogen).
Electron microscopy
The jejunum was excised from mouse pups at P1, washed
gently with 0.1 M Hepes–NaOH (pH 7.3), cut into small pieces,
and processed for ultrathin-section electron microscopy accord-
ing to standard protocols. For freeze-fracture electron microscopy,
the P1 jejunum was ﬁxed for 1 h at room temperature with 2%
glutaraldehyde in 0.1 M Hepes–NaOH (pH 7.3), washed three
times with the Hepes buffer alone, immersed for 2 h in the Hepes
buffer containing 30% glycerol, and then frozen in liquid nitrogen.
The frozen samples were fractured at –110 1C with freeze-etching
equipment (EM-19500NFSDT, JEOL). All samples were observed
with a JEM1010 (JEOL) electron microscope at an acceleration
voltage of 100 kV.
Barrier function assays
The barrier function assay based on sulfo-NHS-biotin was
performed as described previously (Tamura et al., 2008). In brief,
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abdominal cavity was opened. A 30-gauge needle was inserted
into the upper portion of the duodenum near the junction with
the stomach, and 0.2 ml of sulfo-NHS-biotin (1 mg/ml; Sigma)
was injected into the lumen of the intestine. The embryos were
incubated in a humidiﬁed chamber for 30 min at room tempera-
ture, after which the small intestine was cut into four pieces. The
tissue was washed in PBS for 5 min, ﬁxed overnight at 4 1C with
4% paraformaldehyde in PBS, dehydrated, embedded in OCT
compound, and sectioned. The sections were incubated for 1 h
at room temperature with a 1:500 dilution of Alexa Fluor 488-
conjugated streptavidin (Invitrogen) and then processed for
ﬂuorescence microscopy. For assay of Lucifer yellow ﬂux, jejunal
sheets were excised from P3.5 pups and mounted in a dual-
channel Ussing chamber (opening of 0.0314 cm2 between the two
halves of the chamber). Each side of the chamber was ﬁlled with
3 ml of a solution containing 120 mM NaCl, 10 mM Hepes–NaOH
(pH 7.4), 5 mM KCl, 10 mM NaHCO3, 1.2 mM CaCl2, and 1 mM
MgSO4. Lucifer yellow (457.25 Da; Nacalai Tesque) was added
to the serosal/mucosal side of the chamber at a ﬁnal concentra-
tion of 0.5 mg/ml. After incubation of the chamber for 60 min at
37 1C, tissue permeability was determined by removal of the
medium from the mucosal/serosal side of the chamber not
initially containing Lucifer yellow for measurement of dye ﬂuor-
escence with a microplate ﬂuorescence reader.
Culture of duodenum explants with MG132
WT or EpCAM/ duodenums were excised from E18.5
embryo. Immediately after dissection, duodenum explants were
cultured in 50% Rat Serum and 50% DMEM medium with or
without MG132 (10 mg/ml) for 24 h. After 24 h, duodenum
explants were ﬁxed by 4% PFA and were stained for claudin-7.Fig. 1. Intestinal defects in EpCAM mutant mice: (A) macroscopic morphology of
the intestine of WT and EpCAMbgeo/bgeo mouse pups at P1 and P6. The mutant
intestine appears normal at P1, but severe intestinal bleeding is evident at P6.
Bars, 1 mm. (B) Hematoxylin–eosin (H&E) staining of the intestine of EpCAMbgeo/þ
and EpCAMbgeo/bgeo mice at P5. The morphology of the duodenum and jejunum of
the mutant pups was abnormal, with the subepithelial regions of these segments
being devoid of content, whereas the ileum and colon remained normal. Bars,
50 mm. (C) Frozen sections of the small intestine of WT, EpCAMbgeo/bgeo, or
EpCAM–/– mice at P0 were subjected to immunoﬂuorescence staining with
antibodies to EpCAM. Nuclei were also stained with DAPI. Bar, 20 mm.Results
EpCAM mutant mice exhibit intestinal defects
We previously searched for pluripotency-associated genes in
the mouse P19 embryonal carcinoma cell line and its derivatives
(Saijoh et al., 1996), and we found that EpCAM is expressed at a
high level in undifferentiated P19 cells but is down-regulated in
differentiated P19 cells (Fig. S1A) (Shimazaki et al., 1993). In the
developing mouse embryo, EpCAM is expressed speciﬁcally in the
inner cell mass of the blastocyst, in the epiblast at embryonic day
(E) 5.5 and E6.5, and in the developing gonads at E12.5 (Fig. S1B).
This expression pattern is similar to that of Oct3/4 (Saijoh et al.,
1996; Scholer et al., 1990), a functional marker of pluripotency.
To determine the physiological function of EpCAM, we gener-
ated mice deﬁcient in this protein. Two types of mutant allele
were generated: EpCAM– and EpCAMbgeo (Fig. S2). The phenotypes
of EpCAM–/– and EpCAMbgeo/bgeo mice were indistinguishable,
suggesting that both alleles are null. In fact, EpCAM protein was
not detected in the intestine of EpCAM–/– or EpCAMbgeo/bgeo mice
(Fig. S3A and B). Examination of newborn offspring of hetero-
zygote intercrosses revealed that the frequency of homozygous
mutant mice was slightly smaller than expected (22.43% for
EpCAM–/– and 13.76% for EpCAMbgeo/bgeo) (Table S1), suggesting
that the mutant alleles are embryonic lethal in a small proportion
of mutant homozygotes. A previous study found that EpCAM
mutant mice die during embryogenesis as a result of impaired
development of the placenta (Nagao et al., 2009). The homozy-
gous mutant mice in the present study had a body size similar to
that of wild-type (WT) mice at birth and were able to take milk
from the mother. However, the mutant mice had diarrhea and didnot gain body weight, with most dying within 10 days after birth
(Fig. S4). Examination of abdominal organs revealed that the
intestine was most prominently affected in the mutant animals.
At the newborn stage [postnatal day (P) 0 to P1], the intestine of
the mutant mice appeared relatively normal both macroscopically
(Fig. 1A) and histologically (Fig. S5). At P4, however, bleeding was
apparent within the mutant intestine, rendering it brown in color
(data not shown). At P6, severe intestinal bleeding and obstruc-
tion were evident in the mutant mice (Fig. 1A). Perforation was
also observed at many sites of the mutant intestine. Histological
analysis revealed disruption of mucosal architecture and slough-
ing epithelial cells in the mutant intestine at P5, which were more
Fig. 2. Colocalization of EpCAM with claudin-7 in the intestine: (A) immuno-
ﬂuorescence staining of the duodenum of E18.5 WT mice with both antibodies to
EpCAM and those to either E-cadherin (Ecad, panels a), ZO-1 (panels b), or claudin-
7 (Cldn7, panels c). EpCAM localized not only to apical junctions containing
E-cadherin and ZO-1 but also to the lateral membrane of neighboring epithelial
cells. It also colocalized extensively with claudin-7 along the lateral cell mem-
brane of epithelial cells, indicating that claudin-7 is not a speciﬁc TJ marker. Bars,
20 mm. (B) Lysates of the intestine of E18.5 WT mice were subjected to
immunoprecipitation (IP) with antibodies to EpCAM, to claudin-7, to claudin-3,
to claudin-2, or to claudin-15 or with control rabbit IgG. The resulting precipitates
as well as the original lysates (Input) were subjected to immunoblot (IB) analysis
with the same antibodies as indicated. ‘‘Preclear’’ lanes represent proteins
precipitated from lysates with protein G before incubation with antibodies.
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(Fig. 1B).
Given the impaired epithelial architecture, we examined
whether intestinal stem or progenitor cells are maintained in
the mutant mice. In the normal intestine, Ki67-positive (prolifer-
ating) cells are localized to the intervillus domains between villi
at both embryonic and adult stages (Fig. S6A) (van der Flier et al.,
2009). The number of Ki67-positive cells in intervillus domains of
EpCAM mutant mice at E18.5 was similar to that in WT animals
throughout the intestine (Fig. S6A). Intestinal stem cells, which
express Lgr5, are also located in intervillus domains (Kim et al.,
2012). Again, the number of Lgr5-expressing cells in the intestine
of mutant mice was similar that in WT controls (Fig. S6B). These
results thus suggested that intestinal stem and progenitor cells as
well as regulation of their cell cycle are maintained in the
intestine of EpCAM mutant mice. Enterocytes, which are positive
for b-galactosidase and alkaline phosphatase and (Fig. S7A and B),
and goblet cells positive for alcian blue staining (Fig. S7C) were
maintained in the intestine of EpCAM mutant mice, suggesting
that intestinal cell types are correctly speciﬁed in the absence of
EpCAM. Apoptosis was not apparent either in the wild-type or
EpCAM mutant mice (Fig. S7D).
EpCAM is highly expressed in the developing intestine
In WT mice, EpCAM mRNA was detected in the developing gut
from E9.5 to E15.5 as well as throughout the intestine, from the
duodenum to the colon, at E18.5 (Fig. S8). EpCAM protein was
found in villi and intervillus domains and was localized to cell–
cell junctions of the intestinal epithelium at E18.5 and at P0
(Figs. 1C and 2A). As expected, EpCAM protein was not detected in
the intestine of EpCAM–/– or EpCAMbgeo/bgeo mice (Fig. 1C, Fig. S2B).
Staining of the intestinal epithelium of WT mice with both anti-
bodies to EpCAM and either those to E-cadherin or those to ZO-1,
markers of adherens junctions (AJs) and tight junctions (TJs),
respectively, revealed that EpCAM is localized to TJs, AJs and the
lateral membranes of the epithelial cells lining the mouse intestines
(Fig. 2A).
Claudin proteins are down-regulated in the intestine of EpCAM
mutant mice
We next examined the expression of proteins that contribute
to cell–cell junctions, including that of claudin-7, which interacts
with EpCAM in cultured tumor cells (Kuhn et al., 2007; Ladwein
et al., 2005) and is one of the major claudin proteins expressed in
the intestine (Fujita et al., 2006) (Fig. 3). In EpCAM mutant
embryos at E18.5, however, claudin-7 was down-regulated to
undetectable levels in all regions of the intestine examined,
including the duodenum, jejunum, ileum, and colon (Fig. 3A,
Fig. S3B). Claudin-7 was thus undetectable not only at cell–cell
junctions but also in the interior of intestinal cells. Furthermore,
whereas claudin-7 is expressed in the epithelium of the normal
developing gut at E12.5, E13.5, and E14.5, it was undetectable in
the developing gut of the mutant mice at any stage examined
(Fig. 3B).
Mice lacking claudin-7 manifest renal salt wasting and chronic
dehydration and intestinal anomalies similar to those of EpCAM
mutant mice (Ding et al., 2012; Tatum et al., 2010). To examine
whether deﬁciency of claudin-7 alone is responsible for intestinal
defects of the EpCAMmutant mouse, we examined the expression
of additional junctional proteins, including other claudins as well
as AJ and desmosome proteins. Claudin-3 is predominantly
expressed in intervillus domains of the developing intestine in
WT mice; its abundance was reduced in the intestine of EpCAM
mutant mice at P0, however, with this effect being mostprominent in the duodenum and jejunum (Fig. 4A). Claudin-15,
which is normally expressed at TJs of the intestinal epithelium
(Fujita et al., 2006), was also down-regulated in the mutant
intestine, especially in the duodenum and jejunum (Fig. 4B).
Whereas claudin-2 was detected in intestinal villi and intervillus
domains of WT mice at P0, it was down-regulated in the mutant
intestine (Fig. 4C). The expression of other cell–cell junctional
proteins examined, including E-cadherin, b-catenin, and occludin,
appeared normal in the intestine of EpCAM mutant mice (Fig. S9).
These results thus suggested that deﬁciency of multiple claudin
Fig. 3. Down-regulation of claudin-7 in the intestinal epithelium of EpCAM
mutant mice: (A) immunoﬂuorescence staining of claudin-7 in the epithelium of
the duodenum, jejunum, ileum, and colon of WT and EpCAMbgeo/bgeo mouse
embryos at E18.5. Bars, 20 mm. (B) Immunoﬂuorescence or immunohistochemical
staining of claudin-7 in the small intestinal epithelium of WT and EpCAMbgeo/bgeo
mouse embryos at E14.5, E13.5, and E12.5. Bars, 50 mm. (C) In situ hybridization
(ISH) analysis of claudin-7 mRNA and immunohistochemical (IHC) analysis of
claudin-7 protein in the duodenal epithelium of WT and EpCAMbgeo/bgeo mouse
embryos at E18.5. The sections for the two types of analysis are from the same
animals. Bars, 50 mm.
Fig. 4. Down-regulation of claudins 2, 3, and 15 in the intestinal epithelium of
EpCAM mutant mice. Immunohistochemical staining of claudin-3 (A), claudin-15
(B) and claudin-2 (C) in the epithelium of the duodenum, jejunum, ileum, and
colon of WT and EpCAM–/– mouse pups at P0. Claudin-3 and claudin-15 localized
to the apical surface of intervillus domains in the intestine of WT mice and were
down-regulated in the mutant. Claudin-2 is localized to the apical surface of
intestinal villi and intervillus domains in the WT mouse and it is down-regulated
in the mutant. Bars, 50 mm.
Z. Lei et al. / Developmental Biology 371 (2012) 136–145140proteins at cell–cell junctions might be responsible for the
intestinal defects of EpCAM mutant mice.
EpCAM interacts with claudins in the intestinal epithelium
Claudin-7, like EpCAM, is abundantly localized to lateral
membrane while other claudins localize mainly to apical TJs in
the intestinal epithelium. Whereas the abundance of claudin-7
protein was greatly reduced in the intestine of EpCAM mutant
mice, that of claudin-7 mRNA was not (Fig. 3C), suggesting thatthe down-regulation of claudin-7 expression occurs at a post-
transcriptional level. Consistent with previous observations with
human tissue and cultured cells (Ladwein et al., 2005), EpCAM
and claudin-7 were found to be colocalized at cell–cell junc-
tions of the normal mouse intestinal epithelium (Fig. 2A). We
then examined whether EpCAM interacts with claudin-7 in the
Z. Lei et al. / Developmental Biology 371 (2012) 136–145 141intestinal epithelium. Co-immunoprecipitation analysis with the
intestine of WT mice revealed that claudin-7 was present in the
precipitates obtained with antibodies to EpCAM and vice versa
(Fig. 2B). Together, our results thus suggested that EpCAM
interacts with claudin-7 to form a complex in the intestinal
epithelium, and that localization of claudin-7 to the membrane
requires EpCAM. EpCAM also formed a complex with other
claudin proteins, including claudins 2, 3, and 15, although the
interaction with claudin-15 appeared relatively weak (Fig. 2B).
EST expression data (NCBI) suggested that the genes for
EpCAM and claudin-7 are also coexpressed in other organs
including lung, pancreas, stomach, and kidney. We therefore
examined the expression and localization of claudin-7 in these
organs of WT and EpCAM mutant embryos. EpCAM and claudin-7
were indeed found to be coexpressed and colocalized in epithelia
of these organs in WT embryos (Fig. 5A). Claudin-7 was notFig. 5. Down-regulation of claudin-7 in various organs of EpCAMmutant mice: (A)
immunoﬂuorescence staining of EpCAM and claudin-7 in lung, stomach, pancreas,
and kidney of WT mice at E18.5. The two proteins colocalized in the epithelia of
these organs. (B) Immunoﬂuorescence staining of claudin-7 in lung, stomach,
pancreas, and kidney of WT and EpCAMbgeo/bgeo mouse embryos at E18.5. All bars,
20 mm.detected in epithelia of the lung, stomach, and pancreas of EpCAM
mutant mice, but it was detected in the kidney of EpCAM mutant
mice albeit at a reduced level (Fig. 5B).
Barrier function is impaired in the EpCAM mutant intestinal
epithelium
Given that TJs are required for paracellular barrier function
(Tsukita and Furuse, 2002; Tsukita et al., 2008), we next examined
the barrier function of the intestinal epithelium. Injection of
sulfo-NHS-biotin, a probe that physically labels cell membrane
proteins, into the intestinal lumen of E18.5 WT embryos revealed
that the resulting biotin signal at the basal membrane of epithe-
lial cells in the jejunum was less intense than that at the apical
membrane (Fig. 6A). In contrast, similar analysis of the intestine
of EpCAM mutant mice showed that the biotin signal at the basal
membrane was similar to that at the apical membrane (Fig. 6A).
In addition, the intensity of the biotin signal at the lateral
membrane of the intestinal epithelium was higher for the mutant
mice than for WT mice (Fig. 6A). These results thus suggested that
the barrier function of TJs is impaired in the EpCAM mutant
animals. Given that the intestine of the mutant mice does not
exhibit histological anomalies at E18.5, the impaired barrier
function is not likely due to macroscopic structural damage to
the intestine. We further evaluated barrier function with a
quantitative assay based on a low molecular weight probe, Lucifer
yellow. The apical to basal ﬂux as well as the basal to apical ﬂux of
this probe were increased in the intestine of EpCAM mutant mice
at P3.5 (Fig. 6B). Together, our results suggested that the barrier
function of the intestine is impaired in EpCAM mutant mice, most
likely as a result of the down-regulation of claudins such as
claudins 2, 3, 7, and 15 at TJs.
Claudin-2 and claudin-15 are responsible for paracellular
permeability of Naþ (Tamura et al., 2011). In EpCAM mutant
mice in which claudin-2 and claudin-15 are down-regulated
(Fig. 4), NaCl-dilution potential was lowered (Fig. 6C). Naþ-
selective paracellular permeability was reduced while Cl-selec-
tive permeability remained normal (Fig. 6C), like in the claudin-
15 mutant mouse (Tamura et al., 2011).
Structural anomalies of tight junctions in the intestinal epithelium of
EpCAM mutant mice
Finally, we examined the structural integrity of cell–cell
junctions in the intestinal epithelium by electron microscopy at
P1, the stage when the intestine of the mutant mice appeared
relatively normal both macroscopically (Fig. 1A) and histologi-
cally (Suppl. Fig. 5). Freeze-fracture electron microscopy revealed
the branching network of sealing strands of TJs apparent in the
intestinal epithelium of WT mice to be scattered and dispersed in
that of the mutant mice (Fig. 7A). Analysis of ultrathin sections
(Fig. 7B) revealed the presence of cell–cell junctions including TJs,
AJs, and desmosomes in the intestinal epithelium of WT mice. In
the intestinal epithelium of EpCAM mutant mice, however, TJs
expanded and appeared markedly dispersed and less well orga-
nized (Fig. 7B). On the other hand, the structure of AJs appeared to
be normal in the mutant animals (Fig. 7A). These structural
anomalies of TJs likely account for the impaired barrier function
of the mutant intestinal epithelium (Fig. 6).Discussion
We have uncovered a role for EpCAM in formation of func-
tional TJs of the intestinal epithelium. TJs form a barrier that
separates the apical from the basolateral membrane of the
Fig. 6. Impaired barrier function of the intestinal epithelium in EpCAM mutant mice: (A) ﬂuorescence staining of proteins labeled with sulfo-NHS-biotin in the jejunum
after injection of the probe into the lumen of the intestine of WT or EpCAM–/– embryos at E18.5. Whereas the biotin signal at the basal membrane is less intense than that at
the apical membrane for the WT intestine, it is similar to that at the apical membrane for the mutant intestine. The biotin signal at the lateral membrane of the epithelium
is also more intense for the mutant embryo than for the WT embryo. Bars, 20 mm. (B) Measurement of the ﬂux of Lucifer yellow from the apical to basal side and from the
basal to apical side of the jejunum isolated from WT or EpCAM–/– mouse pups at P3.5. Data are means7SEM from 10 (apical to basal) or 8 (basal to apical) independent
experiments. (C) Electrophysiologic analyses were performed as described previously (Tamura et al., 2011). Analyses of the ionic conductances across the small intestine of
WT or EpCAM–/– mice at P3.5 show that transepithelial conductance remains relatively normal in the EpCAM–/– mouse (left panel). Transepithelial NaCl dilution potentials
across the small intestine of WT or EpCAM–/– mice at P3.5 suggest that permeability for NaCl is signiﬁcantly reduced in the EpCAM–/– mouse (the middle panel). Naþ
paracellular permeability is reduced while Cl paracellular permeability does not change in the EpCAM–/– mouse (right panel).
Z. Lei et al. / Developmental Biology 371 (2012) 136–145142epithelium, allowing the selective passage of ions and solutes
(Van Campenhout et al., 2011). Members of the claudin family,
which includes at least 27 proteins in human and mouse (Mineta
et al., 2011; Tsukita and Furuse, 2002; Tsukita et al., 2008; Van
Itallie and Anderson, 2006; Yu and Turner, 2008), are essential
components of TJs (Angelow et al., 2008). They have been shown
to determine not only the barrier function but also the para-
cellular permeability of epithelial cell sheets in culture (Colegioet al., 2002; Furuse and Tsukita, 2006; Van Itallie and Anderson,
2006). The combined down-regulation of claudins-2, 3, 7, and 15
observed in the intestinal epithelium of EpCAM mutant mice in
the present study might thus account for the impaired barrier
function in the intestine of these animals. In fact, a recent study
(Ding et al., 2012) reported that mutant mouse lacking claudin-7
manifests intestinal defects similar to those of the EpCAM mutant
mice. With the barrier function impaired, large molecules such as
Fig. 7. Aberrant structure of tight junctions in the intestinal epithelium of EpCAM
mutant mice: (A) freeze-fracture electron micrographs showing TJ strands in
the jejunum of WT and EpCAMbgeo/bgeo (KO) mice at P1. Bar, 200 nm.
(B) Transmission electron micrographs of ultrathin sections showing TJs (pink)
and AJs (blue) in the jejunal epithelium of WT and EpCAMbgeo/bgeo (KO) mouse
pups at P1. Bar, 200 nm.
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which may be the reason for the intestinal erosion found in the
EpCAM mutant mouse. In this regard, it is interesting to note that
the intestinal defects of EpCAM mutant mice were more severe in
the upper parts of the intestine (Fig. 1B), where proteases are
more abundant.
Our results suggest that EpCAM contributes to the formation
of a functional barrier in the intestinal epithelium by recruiting
claudins to TJs. An EpCAM mutant mouse line generated pre-
viously did not survive beyond E12.5 and manifested embryonic
mortality as a result of placental defects (Nagao et al., 2009).
Although a small portion of our lines of EpCAM mutant mice may
be embryonic lethal, we did not observe a substantial loss of
mutant embryos during pregnancy. Although the two studies
adopted different targeting strategies, it is likely that they both
resulted in the generation of functionally null alleles. The genetic
background of the mice was also 129/C57B6 in both studies. Thereason for the discrepancy in embryonic lethality therefore
remains unknown.
EpCAM is expressed in embryonic and somatic stem cells and
is implicated in pluripotency. Although our EpCAM mutant mice
appear to develop normally until birth, a maternal contribution of
EpCAM might have prevented early embryonic death of the
mutant animals. A minor proportion (3/50, 6%) of the mutant
mice survives until adulthood, with both males and females being
fertile. EpCAM therefore appears to be dispensable for germ cell
formation, even though it is highly expressed in primordial germ
cells (Fig. S1B). Such EpCAM mutant mice that survive until
adulthood should prove useful for investigation of the possible
role of EpCAM in maintenance of somatic stem cells such as those
in the liver (Okabe et al., 2009; Schmelzer et al., 2006) as well as
that of cancer stem cells.
We found that EpCAM and claudin-7 are colocalized not only
at TJs but also at the lateral membrane of intestinal epithelial
cells. Electron microscopy of ultrathin sections revealed that TJs
are structurally abnormal in the intestinal epithelium of EpCAM
mutant mice. However, AJs appear structurally normal and
accordingly the level of membrane-associated E-cadherin was
maintained in the mutant. These observations suggest that
EpCAM may be speciﬁcally required to form functional TJs by
recruiting claudins to TJ. Down-regulation of TJ-localized claudins
such as claudin 2, 3, 15 might have made major contribution to
the speciﬁc defects of TJs. In general, formation of TJs and that of
AJs appear to affect each other since AJs and TJs are intercon-
nected. Indeed, AJs have been found to be necessary for the
establishment of TJs (Gladden et al., 2010), and some TJ proteins
are mislocalized and functional TJs are not formed in the absence
of a-catenin or cadherin (Tinkle et al., 2008; Tunggal et al., 2005;
Vasioukhin et al., 2001). Under certain conditions, however, AJs
may be formed normally even when structural integrity of TJ is
compromised.
Claudin-7 was the most extensively down-regulated claudin in
the intestinal epithelium of EpCAM mutant mice. However, the
combined down-regulation of multiple claudins may thus under-
lie the intestinal defects of EpCAM mutant mice. Claudin-7
localizes to TJs and the lateral membrane of epithelial cells in
many mouse and human tissues (Ladwein et al., 2005; Tatum
et al., 2010). What then is the mechanism by which claudin-7 is
down-regulated to undetectable levels in the intestine of EpCAM
mutant mice? Given that the abundance of claudin-7 mRNA was
maintained in the intestine of these animals, the reduction in the
amount of claudin-7 protein appears to occur at a posttranscrip-
tional step. Previous studies (Kuhn et al., 2007; Ladwein et al.,
2005) and our present results suggest that EpCAM associates with
claudin-7 in various cultured cells and tissues. Interaction with
EpCAM may result in the recruitment of claudin-7 to AJs and TJs,
such that, in the absence of EpCAM, claudin-7 becomes misloca-
lized and susceptible to degradation by the ubiquitin-proteasome
system. However, treatment of duodenum explants from EpCAM
mutant mice with MG132 (a proteasome inhibitor) did not
increase the level of claudin-7 (Fig. S10), suggesting claudin-7
may be degraded by some other mechanism such as the one
involving the lysosome. Whereas claudin-7 was also not detected
in the lung, stomach, and pancreas of EpCAM mutant mice, it was
still detected in the kidney epithelium, albeit at reduced levels.
The kidney epithelium may thus express an EpCAM-like protein
that associates with claudin-7. Tacstd2 is a candidate for such an
EpCAM-like molecule, given that it is not only structurally related
to EpCAM but it also interacts with claudin-1 and claudin-7 in
human tissues and cultured cells and its knockdown reduces the
levels of these claudins (Nakatsukasa et al., 2010).
In addition to claudin-7, the levels of claudins 2, 3, and 15
were also reduced in the intestine of EpCAMmutant mice. EpCAM
Z. Lei et al. / Developmental Biology 371 (2012) 136–145144may therefore directly interact with a variety of claudins and
recruit them to cell–cell junctions including AJs and TJs. Claudin
molecules associate with each other in a heterotypic as well as
homotypic manner in cultured cells (Daugherty et al., 2007;
Furuse et al., 1999; Piontek et al., 2008). We found that claudins
2, 3, 7, and 15 were coprecipitated with each other from intestinal
lysates. However, as mentioned above, the distribution and
expression level of claudins 2, 3, 4, and 8 in the kidney were
not affected in claudin-7 knockout mice (Tatum et al., 2010). The
precise manner of interaction between EpCAM and various
claudins therefore remains to be determined.Acknowledgments
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